柴胡皂苷D对甲状腺乳头状癌细胞TPC-1生物学行为的影响

doi:10.3877/cma.j.issn.2095-1221.2022.04.002

目的

探讨柴胡皂苷D对体外甲状腺乳头状癌（PTC）细胞TPC-1增殖、侵袭、迁移、活性氧和凋亡的影响。

方法

不同浓度（0、5、10、20 μmol/L）柴胡皂苷D干预TPC-1细胞，CCK-8法检测细胞增殖率；Annexin-V-FITC/PI双染试剂盒检测细胞凋亡率；活性氧试剂盒检测细胞活性氧；Transwell小室法检测细胞侵袭、迁移能力；Western blot法检测凋亡蛋白剪切的半胱天冬酶3 （cleaved caspase 3）、B淋巴细胞瘤-2基因（Bcl-2）、Bcl2相关X蛋白（Bax）和侵袭迁移相关蛋白E钙黏蛋白（E-cadherin)和N钙黏蛋白（N-cadherin）及Wnt/β连环蛋白（β-catenin）信号通路相关蛋白Wnt3a和β-catenin的表达量。多组间比较采用单因素方差分析，组间两两比较采用LSD-t检验。

结果

与0 μmol/L柴胡皂苷D干预相比，（5、10、20 μmol/L）柴胡皂苷D干预TPC-1细胞存活率[24 h：（88.07±0.75）%、（76.06±0.56）%、（65.80± 1.66）%比（100.00±1.00）%；48 h：（72.40±0.35）%、（52.26± 0.22）%、（41.30±0.17）%比（100.00± 1.53）%；72 h：（56.50±0.22）%、（40.26±0.21）%、（31.10± 0.14）%比（100.00±0.14）%]、细胞侵袭率[（65.43±1.32）%、（49.46±0.31）%、（22.48±0.85）%比（100.00±1.25）%]、迁移率[（67.45±0.96）%、（52.42±0.39）%、（42.12±1.10）%比（100.00±2.00）%]、Bcl-2蛋白表达量（0.51±0.02、0.31±0.02、0.22±0.02比0.62±0.01）、Wnt3a表达量（0.56±0.06、0.37±0.01、0.26±0.02比0.72±0.03）、β-catenin表达量（0.59±0.02、0.40±0.03、0.14±0.03比0.82±0.03）和N-cadherin表达量（0.49±0.05、0.34 ±0.03、0.14± 0.03比0.62±0.05）均降低，细胞活性氧含量增加，凋亡率[（12.36±1.32）%、（23.15±2.27）%、（36.65±3.22）%比（7.32±1.25）%]、Bax蛋白表达量（0.45±0.02、0.51±0.01、0.79±0.02比0.32±0.01）、cleaved caspase-3蛋白表达量（0.26±0.02、0.37±0.02、0.40±0.02比0.13±0.01）和E-cadherin表达量（0.20±0.02、0.37±0.02、0.46±0.05比0.12±0.01）均增加（P均< 0.05）。

结论

柴胡皂苷D能够抑制PTC细胞的生物学行为。

关键词: 甲状腺乳头状癌, 柴胡皂苷D, 凋亡, 侵袭迁移

Objective

To explore the effect of saikosaponin D on the proliferation, invasion, migration, reactive oxygen species and apoptosis of TPC-1 papillary thyroid carcinoma (PTC) cells in vitro.

Methods

The cells were treated with 0、5、10、20 μmol/L saikosaponin D. The cell proliferation rate was detected by CCK-8 assay. Annexin V conjugate (Annexin V-FITC) and propidium iodide (PI) double staining kit was used to detect cell apoptosis rate. Reactive oxygen detection kit was used to detect cell reactive oxygen species. Transwell chamber method was used to detect cell invasion and migration ability. Western blot was used to detect the expression of apoptosis proteins including cleaved caspase-3, B-cell lymphoma-2 (Bcl-2) , Bcl2 associated X protein (Bax) , invasion and migration related proteins E-cadherin, N-cadherin and Wnt/β-catenin signaling pathway related proteins Wnt3a and β-catenin. At the same time, one-way ANOVA was used to compare multiple groups and the LSD-t test was used for pairwise comparison between groups.

Results

Compared with 0 μmol/L saikosaponin D, 5、10、20 μmol/L saikosaponin D significantly decreased survival rate (24 h: 88.07±0.75, 76.06±0.56, 65.80±1.66 vs 100.00±1.00. 48 h: 72.40±0.35, 52.26±0.22, 41.30±0.17 vs 100.00±1.53. 72 h: 56.50±0.22, 40.26±0.21, 31.10±0.14 vs 100.00±0.14) , cell invasion rate [ (65.43±1.32) %, (49.46±0.31) %, (22.48±0.85) % vs (100.00±1.25) %], mobility[ (67.45±0.96) %, (52.42±0.39) %, (42.12± 1.10) % vs (100.00±2.00) %], Bcl-2 protein expression (0.51±0.02, 0.31±0.02, 0.22±0.02 vs 0.62±0.01) , Wnt3a expression (0.56±0.06, 0.37±0.01, 0.26±0.02 vs 0.72±0.03) , β-catenin expression (0.59±0.02, 0.40±0.03, 0.14±0.03 vs 0.82±0.03) , N-cadherin expression (0.49±0.05, 0.34±0.03, 0.14±0.03 vs 0.62±0.05) in TPC-1 cells. Compared with 0 μmol/L saikosaponin D, 5、10、20 μmol/L saikosaponin D significantly increased the content of reactive oxygen species in cells and the apoptosis rate[ (12.36±1.32) %, (23.15±2.27) %, (36.65±1.32) %vs (7.32±1.25) %], Bax protein expression (0.45±0.02, 0.51±0.01, 0.79±0.02 vs 0.32±0.01) , cleaved caspase-3 protein expression (0.26±0.02, 0.37±0.02, 0.40±0.02 vs 0.13±0.01) and E-cadherin expression (0.20±0.02, 0.37±0.02, 0.46±0.05 vs 0.12±0.01) (all P < 0.05) .

Conclusion

Saikosaponin D can inhibit the biological behavior of PTC cells.

Key words: Papillary thyroid carcinoma, Saikosaponin D, Apoptosis, Invasion and migration

表1 柴胡皂苷D作用于TPC-1细胞后细胞凋亡率及cleaved caspase-3、Bax、Bcl-2蛋白相对表达量（±s）

分组	实验次数	细胞凋亡率	Bax	Bcl-2	cleaved caspase-3
0 μmol/L	3	7.32 ± 1.25	0.32 ± 0.01	0.62 ± 0.01	0.13 ± 0.01
5 μmol/L	3	12.36 ± 1.32^a	0.45 ± 0.02^a	0.51 ± 0.02^a	0.26 ± 0.02^a
10 μmol/L	3	23.15 ± 2.27^ab	0.51 ± 0.01^ab	0.31 ± 0.02^ab	0.37 ± 0.02^ab
20 μmol/L	3	36.65 ± 3.22^abc	0.79 ± 0.02^abc	0.22 ± 0.02^abc	0.40 ± 0.02^abc
F值		192.332	288.673	163.462	212.899
P值		< 0.001	< 0.001	< 0.001	< 0.001

表1 柴胡皂苷D作用于TPC-1细胞后细胞凋亡率及cleaved caspase-3、Bax、Bcl-2蛋白相对表达量（±s）

分组	实验次数	细胞凋亡率	Bax	Bcl-2	cleaved caspase-3
0 μmol/L	3	7.32 ± 1.25	0.32 ± 0.01	0.62 ± 0.01	0.13 ± 0.01
5 μmol/L	3	12.36 ± 1.32^a	0.45 ± 0.02^a	0.51 ± 0.02^a	0.26 ± 0.02^a
10 μmol/L	3	23.15 ± 2.27^ab	0.51 ± 0.01^ab	0.31 ± 0.02^ab	0.37 ± 0.02^ab
20 μmol/L	3	36.65 ± 3.22^abc	0.79 ± 0.02^abc	0.22 ± 0.02^abc	0.40 ± 0.02^abc
F值		192.332	288.673	163.462	212.899
P值		< 0.001	< 0.001	< 0.001	< 0.001

图1 柴胡皂苷D对TPC-1细胞活性氧与凋亡的影响注：a ~ d图为荧光显微镜下观察0、5、10、20 μmol/L柴胡皂苷D干预TPC-1细胞的活性氧，绿色荧光越强表明活性氧含量越高（×100）；e ~ h图分别为0、5、10、20 μmol/L柴胡皂苷D干预TPC-1细胞的凋亡率

图2 Western blot检测cleaved caspase-3、Bax和Bcl-2蛋白相对表达量

表2 柴胡皂苷D作用于TPC-1细胞后侵袭、迁移能力与Wnt3a、β-catenin、E-cadherin、N-cadherin相对表达量（±s）

分组	实验次数	侵袭率（%）	迁移率（%）	Wnt3a	β-catenin	E-cadherin	N-cadherin
0 μmol/L	3	100.00 ± 1.25	100.00 ± 2.00	0.72 ± 0.03	0.82 ± 0.03	0.12 ± 0.01	0.62 ± 0.05
5 μmol/L	3	65.43 ± 1.32^a	67.45 ± 0.96^a	0.56 ± 0.06^a	0.59 ± 0.02^a	0.20 ± 0.02^a	0.49 ± 0.05^a
10 μmol/L	3	49.46 ± 0.31^ab	52.42 ± 0.39^ab	0.37 ± 0.01^ab	0.40 ± 0.03^ab	0.37 ± 0.02^ab	0.34 ± 0.03^ab
20 μmol/L	3	22.48 ± 0.85^abc	42.12 ± 1.10^abc	0.26 ± 0.02^abc	0.14 ± 0.03^abc	0.46 ± 0.05^abc	0.14 ± 0.03^abc
F值		203.602	165.142	187.146	225.14	175.762	182.186
P值		< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001

表2 柴胡皂苷D作用于TPC-1细胞后侵袭、迁移能力与Wnt3a、β-catenin、E-cadherin、N-cadherin相对表达量（±s）

分组	实验次数	侵袭率（%）	迁移率（%）	Wnt3a	β-catenin	E-cadherin	N-cadherin
0 μmol/L	3	100.00 ± 1.25	100.00 ± 2.00	0.72 ± 0.03	0.82 ± 0.03	0.12 ± 0.01	0.62 ± 0.05
5 μmol/L	3	65.43 ± 1.32^a	67.45 ± 0.96^a	0.56 ± 0.06^a	0.59 ± 0.02^a	0.20 ± 0.02^a	0.49 ± 0.05^a
10 μmol/L	3	49.46 ± 0.31^ab	52.42 ± 0.39^ab	0.37 ± 0.01^ab	0.40 ± 0.03^ab	0.37 ± 0.02^ab	0.34 ± 0.03^ab
20 μmol/L	3	22.48 ± 0.85^abc	42.12 ± 1.10^abc	0.26 ± 0.02^abc	0.14 ± 0.03^abc	0.46 ± 0.05^abc	0.14 ± 0.03^abc
F值		203.602	165.142	187.146	225.14	175.762	182.186
P值		< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001

图3 Transwell小室法检测柴胡皂苷D对TPC-1细胞侵袭和迁移的影响（结晶紫染色，×100）注：a ~ d图为倒置荧光显微镜下观察0、5、10、20 μmol/L柴胡皂苷D干预TPC-1细胞的侵袭结果；e ~ h图分别为倒置荧光显微镜下观察0、5、10、20 μmol/L柴胡皂苷D干预TPC-1细胞的迁移结果

图4 Western blot检测Wnt3a、β-catenin、E-cadherin和N-cadherin的相对表达量

1	Liu Y, Zhang H, Wang H, et al. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4[J]. Bioengineered, 2021, 12(1):496-506.
2	Du YL, Liang Y, Cao Y, et al. LncRNA XIST promotes migration and invasion of papillary thyroid cancer cell by modulating MiR-101-3p/CLDN1 Axis[J]. Biochem Genet, 2021, 59(2):437-452.
3	Li Y, Zeng QG, Qiu JL, et al. Propofol suppresses migration, invasion, and epithelial-mesenchymal transition in papillary thyroid carcinoma cells by regulating miR-122 expression[J]. Eur Rev Med Pharmacol Sci, 2020, 24(9):5101-5110.
4	Li C, Xue HG, Feng LJ, et al. The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts[J]. Eur Rev Med Pharmacol Sci, 2017, 21(19):4437-4445.
5	Li Y, Cai T, Zhang W, et al. Effects of Saikosaponin D on apoptosis in human U87 glioblastoma cells[J]. Mol Med Rep, 2017, 16(2):1459-1464.
6	Hsu YL, Kuo PL, Lin CC. The proliferative inhibition and apoptotic mechanism of saikosaponin D in human non-small cell lung cancer A549 cells[J]. Life Sci, 2004, 75(10):1231-1242.
7	Ma Q, Gao FF, He X, et al. Antitumor effects of saikosaponin b2 on breast cancer cell proliferation and migration[J]. Mol Med Rep, 2019, 20(2):1943-1951.
8	Yao M, Yang J, Cao L, et al. Saikosaponind inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase[J]. Mol Med Rep, 2014, 10(1):365-372.
9	Ma X, Dang C, Kang H, et al. Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways[J]. Int Immunopharmacol, 2015, 28(1):399-408.
10	Gao T, Zhao P, Yu X, et al. Use of saikosaponin D and JNK inhibitor SP600125, alone or in combination, inhibits malignant properties of human osteosarcoma U2 cells[J]. Am J Transl Res, 2019, 11(4):2070-2080.
11	Tang JC, Long F, Zhao J, et al. The effects and mechanisms by which saikosaponin-d enhances the sensitivity of human non-small cell lung cancer cells to gefitinib[J]. J Cancer, 2019, 10(26):6666-6672.
12	Zhong D, Zhang HJ, Jiang YD, et al. Saikosaponin-d: A potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes[J]. Biochem Biophys Res Commun, 2016, 474(4):722-729.
13	Tian YD, Lin S, Yang PT, et al. Saikosaponin-d increases the radiosensitivity of hepatoma cells by adjusting cell autophagy[J]. J Cancer, 2019, 10(20):4947-4953.
14	Cai C, Zhang H, Ou Y, et al. Saikosaponin-d suppresses cell growth in renal cell carcinoma through EGFR/p38 signaling pathway[J]. Neoplasma, 2017, 64(4):518-525.
15	He S, Lu G, Hou H, et al. Saikosaponind suppresses the expression of cyclooxygenase2 through the phosphosignal transducer and activator of transcription 3/hypoxiainducible factor1α pathway in hepatocellular carcinoma cells[J]. Mol Med Rep, 2014, 10(5):2556-2562.
16	Zhao L, Li J, Sun Z, et al. Saikosaponin D inhibits proliferation of human osteosarcoma cells via the p53 signaling pathway[J]. Exp Ther Med, 2019, 17(1):488-494.
17	Sun K, Du Y, Hou Y, et al. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/mA signaling[J]. Theranostics, 2021, 11(12):5831-5846.
18	Tsuyoshi H, Wong VKW, Han Y, et al. Saikosaponin-d, a calcium mobilizing agent, sensitizes chemoresistant ovarian cancer cells to cisplatin-induced apoptosis by facilitating mitochondrial fission and G2/M arrest[J]. Oncotarget, 2017, 8(59):99825-99840.
19	Zhou P, Shi W, He X, et al. Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics[J]. Pharm Biol, 2021, 59(1):1480-1489.
20	Chen X, Liu C, Zhao R, et al. Synergetic and antagonistic molecular effects mediated by the feedback loop of p53 and JNK between saikosaponin D and SP600125 on lung cancer A549 cells[J]. Mol Pharm, 2018, 15(11):4974-4984.
21	Liu RY, Li JP. Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest[J] .Eur Rev Med Pharmacol Sci, 2014, 18(17):2435-2443.
22	Lv Y, Hou X, Zhang Q, et al. Untargeted metabolomics study of the in vitro anti-hepatoma effect of saikosaponin D in combination with NRP-1 knockdown[J]. Molecules, 2019, 24(7):1423. doi:10.3390/molecules24071423.
23	Wang B, Min W, Lin S, et al. Saikosaponin-d increases radiation-induced apoptosis of hepatoma cells by promoting autophagy via inhibiting mTOR phosphorylation[J]. Int J Med Sci, 2021, 18(6):1465-1473.
24	Wu S, Chen W, Liu K, et al. Saikosaponin D inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by inhibiting the STAT3 pathway[J] J Int Med Res, 2020, 48(9):300060520937163. doi: 10.1177/0300060520937163.
25	Fu R, Zhang L, Li Y, et al. Saikosaponin D inhibits autophagosome lysosome fusion and induces autophagy independent apoptosis in MDA MB 231 breast cancer cells[J] Mol Med Rep, 2020, 22(2):1026-1034.

[1]	钟雅雯, 王煜, 王海臻, 黄莉萍. 肌苷通过抑制线粒体通透性转换孔开放缓解缺氧/复氧诱导的人绒毛膜滋养层细胞凋亡[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 525-533.
[2]	孙鸿坤, 艾虹, 陈正. 内质网应激介导的牙周炎骨改建失衡的研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 211-218.
[3]	廖泽楷, 梁爱琳, 龚启梅. 根尖周病中程序性细胞死亡的研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 150-155.
[4]	唐亦骁, 陈峻, 连正星, 胡海涛, 鲁迪, 徐骁, 卫强. 白果内酯对小鼠肝缺血再灌注损伤保护作用研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 278-282.
[5]	胡思平, 熊性宇, 徐航, 杨璐. 衰老相关分泌表型因子在前列腺癌发生发展中的作用机制[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 425-434.
[6]	郑俊, 吴杰英, 谭海波, 郑安全, 李腾成. EGFR-MEK-TZ三联合分子的构建及其对去势抵抗性前列腺癌细胞增殖与凋亡的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 503-508.
[7]	李勇, 彭天明, 王倩倩, 陈育纯, 蒲小勇, 刘久敏. 基于失巢凋亡相关基因的膀胱癌预后模型构建及分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 331-339.
[8]	黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[9]	季加翠, 孙春斌, 罗恩丽. 姜黄素通过调节NF-κB/NLRP3通路减轻LPS诱导小胶质细胞神经炎症损伤[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 193-203.
[10]	杜霞, 马梦青, 曹长春. 造影剂诱导的急性肾损伤的发病机制及干预靶点研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 279-282.
[11]	王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
[12]	王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
[13]	靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
[14]	卫星彤, 李昊昌, 赵欣. 甲状腺木乃伊结节于多模态超声下的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 415-419.
[15]	刘霖, 张文欢, 宋雅茹, 姜云璐. Apelin-13 在阿尔茨海默病中的神经保护作用机制研究进展[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 276-280.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Effects of saikosaponin D on the biological behavior of papillary thyroid carcinoma TPC-1

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Effects of saikosaponin D on the biological behavior of papillary thyroid carcinoma TPC-1